Cargando…
Development of novel monoclonal antibodies against starch and ulvan - implications for antibody production against polysaccharides with limited immunogenicity
Monoclonal antibodies (mAbs) are widely used and powerful research tools, but the generation of mAbs against glycan epitopes is generally more problematic than against proteins. This is especially significant for research on polysaccharide-rich land plants and algae (Viridiplantae). Most antibody pr...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570955/ https://www.ncbi.nlm.nih.gov/pubmed/28839196 http://dx.doi.org/10.1038/s41598-017-04307-2 |
_version_ | 1783259256138498048 |
---|---|
author | Rydahl, Maja G. Kračun, Stjepan K. Fangel, Jonatan U. Michel, Gurvan Guillouzo, Alexia Génicot, Sabine Mravec, Jozef Harholt, Jesper Wilkens, Casper Motawia, Mohammed Saddik Svensson, Birte Tranquet, Olivier Ralet, Marie-Christine Jørgensen, Bodil Domozych, David S. Willats, William G. T. |
author_facet | Rydahl, Maja G. Kračun, Stjepan K. Fangel, Jonatan U. Michel, Gurvan Guillouzo, Alexia Génicot, Sabine Mravec, Jozef Harholt, Jesper Wilkens, Casper Motawia, Mohammed Saddik Svensson, Birte Tranquet, Olivier Ralet, Marie-Christine Jørgensen, Bodil Domozych, David S. Willats, William G. T. |
author_sort | Rydahl, Maja G. |
collection | PubMed |
description | Monoclonal antibodies (mAbs) are widely used and powerful research tools, but the generation of mAbs against glycan epitopes is generally more problematic than against proteins. This is especially significant for research on polysaccharide-rich land plants and algae (Viridiplantae). Most antibody production is based on using single antigens, however, there are significant gaps in the current repertoire of mAbs against some glycan targets with low immunogenicity. We approached mAb production in a different way and immunised with a complex mixture of polysaccharides. The multiplexed screening capability of carbohydrate microarrays was then exploited to deconvolute the specificities of individual mAbs. Using this strategy, we generated a set of novel mAbs, including one against starch (INCh1) and one against ulvan (INCh2). These polysaccharides are important storage and structural polymers respectively, but both are generally considered as having limited immunogenicity. INCh1 and INCh2 therefore represent important new molecular probes for Viridiplantae research. Moreover, since the α-(1-4)-glucan epitope recognised by INCh1 is also a component of glycogen, this mAb can also be used in mammalian systems. We describe the detailed characterisation of INCh1 and INCh2, and discuss the potential of a non-directed mass-screening approach for mAb production against some glycan targets. |
format | Online Article Text |
id | pubmed-5570955 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-55709552017-09-01 Development of novel monoclonal antibodies against starch and ulvan - implications for antibody production against polysaccharides with limited immunogenicity Rydahl, Maja G. Kračun, Stjepan K. Fangel, Jonatan U. Michel, Gurvan Guillouzo, Alexia Génicot, Sabine Mravec, Jozef Harholt, Jesper Wilkens, Casper Motawia, Mohammed Saddik Svensson, Birte Tranquet, Olivier Ralet, Marie-Christine Jørgensen, Bodil Domozych, David S. Willats, William G. T. Sci Rep Article Monoclonal antibodies (mAbs) are widely used and powerful research tools, but the generation of mAbs against glycan epitopes is generally more problematic than against proteins. This is especially significant for research on polysaccharide-rich land plants and algae (Viridiplantae). Most antibody production is based on using single antigens, however, there are significant gaps in the current repertoire of mAbs against some glycan targets with low immunogenicity. We approached mAb production in a different way and immunised with a complex mixture of polysaccharides. The multiplexed screening capability of carbohydrate microarrays was then exploited to deconvolute the specificities of individual mAbs. Using this strategy, we generated a set of novel mAbs, including one against starch (INCh1) and one against ulvan (INCh2). These polysaccharides are important storage and structural polymers respectively, but both are generally considered as having limited immunogenicity. INCh1 and INCh2 therefore represent important new molecular probes for Viridiplantae research. Moreover, since the α-(1-4)-glucan epitope recognised by INCh1 is also a component of glycogen, this mAb can also be used in mammalian systems. We describe the detailed characterisation of INCh1 and INCh2, and discuss the potential of a non-directed mass-screening approach for mAb production against some glycan targets. Nature Publishing Group UK 2017-08-24 /pmc/articles/PMC5570955/ /pubmed/28839196 http://dx.doi.org/10.1038/s41598-017-04307-2 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Rydahl, Maja G. Kračun, Stjepan K. Fangel, Jonatan U. Michel, Gurvan Guillouzo, Alexia Génicot, Sabine Mravec, Jozef Harholt, Jesper Wilkens, Casper Motawia, Mohammed Saddik Svensson, Birte Tranquet, Olivier Ralet, Marie-Christine Jørgensen, Bodil Domozych, David S. Willats, William G. T. Development of novel monoclonal antibodies against starch and ulvan - implications for antibody production against polysaccharides with limited immunogenicity |
title | Development of novel monoclonal antibodies against starch and ulvan - implications for antibody production against polysaccharides with limited immunogenicity |
title_full | Development of novel monoclonal antibodies against starch and ulvan - implications for antibody production against polysaccharides with limited immunogenicity |
title_fullStr | Development of novel monoclonal antibodies against starch and ulvan - implications for antibody production against polysaccharides with limited immunogenicity |
title_full_unstemmed | Development of novel monoclonal antibodies against starch and ulvan - implications for antibody production against polysaccharides with limited immunogenicity |
title_short | Development of novel monoclonal antibodies against starch and ulvan - implications for antibody production against polysaccharides with limited immunogenicity |
title_sort | development of novel monoclonal antibodies against starch and ulvan - implications for antibody production against polysaccharides with limited immunogenicity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570955/ https://www.ncbi.nlm.nih.gov/pubmed/28839196 http://dx.doi.org/10.1038/s41598-017-04307-2 |
work_keys_str_mv | AT rydahlmajag developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity AT kracunstjepank developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity AT fangeljonatanu developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity AT michelgurvan developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity AT guillouzoalexia developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity AT genicotsabine developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity AT mravecjozef developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity AT harholtjesper developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity AT wilkenscasper developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity AT motawiamohammedsaddik developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity AT svenssonbirte developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity AT tranquetolivier developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity AT raletmariechristine developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity AT jørgensenbodil developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity AT domozychdavids developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity AT willatswilliamgt developmentofnovelmonoclonalantibodiesagainststarchandulvanimplicationsforantibodyproductionagainstpolysaccharideswithlimitedimmunogenicity |